Resapp Health Azione

Resapp Health Numero di Graham

Il Numero di Graham di Resapp Health (RAP.AX) al 12 ago 2026 è 0,01 AUD. L'anno precedente, Numero di Graham era 0,04 AUD — una variazione del -70,54% (inferiore).

Numero di Graham

0,01AUD

YoY

-70,54%

Ultimo aggiornamento:

Numero di Graham di Resapp Health ammonta a 2026 0,01 AUD. Numero di Graham di Resapp Health ammontava a 2025 0,04 AUD. Diminuisce del -70,54% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Resapp Health Analisi delle Azioni

Cosa fa Resapp Health? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Resapp Health azioni

Numero di Graham di Resapp Health è 0,01 AUD nel 2026.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Resapp Health di Numero di Graham dal 2006, con valori annuali, grafici e analisi dettagliate.

Il Graham Number stima il prezzo massimo equo per un'azione sulla base dell'EPS e del valore contabile per azione, seguendo i principi di value investing di Benjamin Graham.

Access this data via the Eulerpool API

Qualità — Resapp Health

Tutte le Metriche Finanziarie — Resapp Health